Sep 02, 2020 / 03:00PM GMT
Paul R. Gudonis - Myomo, Inc. - Chairman, President & CEO
Well, good morning. This is Paul Gudonis, CEO of Myomo. And with me today is David Henry, our Chief Financial Officer. The company, Myomo, is a leader in upper extremity medical robotics to conquer paralysis. We're traded on the New York Stock Exchange American under the symbol MYO. We'll be making some forward-looking statements today, so please read our safe harbor statement here.
Now on to the company. As I said, we are positioned as a leader in providing the MyoPro product line. MyoPro is a myoelectric orthotic, a powered arm brace, that enables people with -- individuals with paralysis to move their arms and hands once again to perform activities of daily living, dress themselves, feed themselves, go to work in some cases. It's a lightweight, portable device approved and registered here with the FDA in the United States, CE marked in Europe. And we are the only commercially available device like this that restores this type of arm function. We shipped about 1,000 devices since inception with a growing number each year, as you'll
Myomo Inc at LD 500 Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot